Lead poisoning and pharmacological treatment

Authors

  • Daniela Fontana
  • Valeria María Lescano
  • Nancy Solá
  • Martinez Samanta
  • Miriam Virgolini
  • Maria Rosa Mazzieri

DOI:

https://doi.org/10.31052/1853.1180.v17.n1.6823

Keywords:

Lead poisoning, public health, chelating agents, drug availability

Abstract

Lead exposure and poisoning is a public health concern. Evidence of people with toxic level of lead in blood confirms that it is necessary to keep on working from a multidisciplinary approach. There should be a well-defined policy for the prevention, detection, diagnosis and treatment of the harmful effects of lead. Children are the population at major risk, with high social impact consequences such as lower IQ and inadequate neurological development. There are four drugs used to treat chronic toxicity: sodium calcium edetate IV and IM, succimer (oral), dimercaprol IM, and penicillamine (oral). If we consider that the last one is the only authorized drug in our country, the problem grows bigger. This brief review offers information about lead exposure and poisoning, the recommended drug treatments and their market availability.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Fontana D, Lescano VM, Solá N, Samanta M, Virgolini M, Mazzieri MR. Lead poisoning and pharmacological treatment. Rev. Salud Pública (Córdoba) [Internet]. 2014 Mar. 18 [cited 2024 May 13];17(1):49-5. Available from: https://revistas.unc.edu.ar/index.php/RSD/article/view/6823

Issue

Vol. 17 No. 1 (2013)

Section

Scientific Articles

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows the work to be copied, distributed, exhibited and interpreted as long as it is not done for commercial purposes.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) after the publication process. (See The Effect of Open Access). (See The Effect of Open Access).

Most read articles by the same author(s)